Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LRRC37B | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | MTURN | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | ARL4C | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | TREML1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
mRNA | PPT2 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | FAM114A1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | ZYG11A | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | TMEM243 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
mRNA | LRCH4 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
mRNA | TTC21A | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |